Objective Measurement of Ossicular Chain Mobility Using a Palpating Instrument Intraoperatively (PalpEar)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02554422 |
|
Recruitment Status :
Completed
First Posted : September 18, 2015
Last Update Posted : September 18, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Disorder of Middle Ear Otosclerosis of Middle Ear Cholesteatoma, Middle Ear | Device: PalpEar | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 32 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Basic Science |
| Official Title: | Messung Der Beweglichkeit Der Gehörknöchelchenkette während Einer Ohroperation. ("Objective Measurements of Ossicular Chain Mobility Using a Palpating Instrument Intraoperatively") |
| Study Start Date : | December 2013 |
| Actual Primary Completion Date : | February 2015 |
| Actual Study Completion Date : | August 2015 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: PalpEar
Intraoperative palpation of the ossicles using the PalpEar device, to measure mobility of the ossicle chain.
|
Device: PalpEar
Palpation of the middle-ear ossicles using the PalpEar device, to measure mobility of the ossicle chain |
- Measurement of the ossicle mobility through the palpation force [ Time Frame: 1 day. The measurements are performed during day 1, in parallel with the underlying surgery, and therefore assessed within the time frame of 1 day. ]The palpation forces needed to move the middle-ear ossicles out from their resting position will be measured through a force sensing device. The measured palpation forces are measured in equivalent gram-force [gF]. The primary outcome of the study is to demonstrate if a relation can be established between the subjective feeling of the surgeon and an objective measurement of the palpation force.
- Difference between normal and impaired ossicular chains [ Time Frame: 1 day. The measurements are performed during day 1, in parallel with the underlying surgery, and therefore assessed within the time frame of 1 day. ]A comparison between ossicular chains judged as "normal" by the surgeon and impaired ossicular chains will be performed, to assess if a significant difference can be extracted from the measurement of the palpation force. This would help in a future diagnosis assisted by a force sensing device.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion criteria:
- Adult subjects
- Normally scheduled for middle-ear or internal-ear surgery as a result of an ear disease and for whom a routine assessment of the mobility of the ossicle chain is in order.
The targeted subject population consists of patients undergoing stapedotomy for otosclerosis and subjects with a normal ossicular chain who are subject to the placement of a cochlear implant to treat hearing loss.
Exclusion criteria:
- Children
- Subjects in whom the ossicle chain is missing or incomplete
- Missing informed consent form
- Incapacitated subjects or subjects with impaired judgment capability.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02554422
| Principal Investigator: | Thomas E. Linder, Prof. MD | Luzerner Kantonsspital |
| Responsible Party: | Sensoptic SA |
| ClinicalTrials.gov Identifier: | NCT02554422 |
| Other Study ID Numbers: |
2013-MD-0014 |
| First Posted: | September 18, 2015 Key Record Dates |
| Last Update Posted: | September 18, 2015 |
| Last Verified: | September 2015 |
|
Otosclerosis Cholesteatoma, Middle Ear Cholesteatoma Keratosis |
Skin Diseases Ear Diseases Otorhinolaryngologic Diseases |

